Obesity Treatment Market Research Report, Demand, Industry Analysis, Share, Growth, Applications, Types and Forecasts Report 2032

The global obesity treatment market reached a value of USD 15.00 billion in 2022, with expectations for rapid growth at a compound annual growth rate (CAGR) of 10.0% over the forecast period. This growth is fueled by the rising prevalence of obesity and advancements in weight loss technology.

Obesity has become a major global health concern, contributing to a variety of serious medical conditions, including cardiovascular diseases, diabetes, musculoskeletal disorders, and certain cancers. With the number of individuals suffering from obesity continuing to rise, the demand for effective treatment options is also increasing. People are becoming more aware of the need for proactive measures such as diet and exercise to combat this issue.

You Can Download Free Sample PDF Copy Of This Report @ https://www.emergenresearch.com/request-sample/2775

Key Market Drivers

A major factor driving the market is the growing prevalence of obesity. According to the World Health Organization (WHO), around 13% of the global population is categorized as obese. The increasing number of obesity-related health issues is contributing to the rising demand for treatment options.

Technology is playing a vital role in obesity management, with digital tools such as Personal Digital Assistants (PDAs) offering users the ability to track their diet and physical activity in real-time. Remote coaching via telehealth services also provides individuals with personalized guidance, improving accessibility and convenience. These tech-driven interventions are proving valuable in supporting behavior changes that promote healthier lifestyles.

Another trend in the market is the growing need for bariatric surgery, as traditional approaches like dietary and pharmaceutical interventions often fail to deliver long-lasting results. Procedures such as gastric bypass, sleeve gastrectomy, and others are gaining popularity due to their ability to achieve significant weight loss and improve obesity-related health conditions.

Market Restraints

Despite this growth, the high cost of treatment remains a challenge. Both individuals and healthcare systems face financial pressures from obesity treatment. The costs associated with medications, monitoring, and healthcare services can limit access to long-term therapeutic options, creating a barrier for some patients.

Market Segmentation Insights

Treatment Type: The obesity treatment market is divided into three key categories: pharmaceuticals, surgical procedures, and dietary and lifestyle interventions. Surgical procedures hold the largest market share due to their proven effectiveness in achieving durable weight loss compared to non-surgical methods. As advancements in surgical techniques have made these procedures safer and more effective, they are increasingly being adopted by individuals with severe obesity.

The pharmaceutical segment is also growing, driven by increasing FDA approvals for weight management medications. The availability of new drugs is making pharmaceutical treatments a trusted option for healthcare providers and patients alike, contributing to market growth.

End-Use: Among the end-users, research and academic institutes hold a significant share of the market. These institutions are critical in developing new obesity treatments, particularly pharmacotherapies that focus on different mechanisms within the body. Hospitals are also witnessing steady growth, as they provide specialized, professional care that is essential for managing the complexities of obesity.

Technology: In terms of technology, the telehealth and digital health solutions segment is leading the market. Telehealth offers patients more convenience and accessibility in managing their obesity treatment plans. Mobile apps and wearable devices are also being used to support weight loss efforts, helping patients track their progress and stay motivated.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/obesity-treatment-market

Minimally invasive surgical technologies are also seeing rapid growth. These techniques, such as laparoscopy, offer patients the advantage of smaller incisions, faster recovery times, and fewer risks, which are driving their adoption.

Obesity Treatment Top Companies and Competitive Landscape

The global obesity treatment market is moderately fragmented, with many large and medium-sized players accounting for majority of market revenue. Major businesses are using a variety of tactics, making mergers and acquisitions, strategic agreements, and contracts, as well as creating, experimenting with, and introducing more efficient obesity treatment solutions.

Some major players included in the global obesity treatment market report are:

Novo Nordisk
Roche
Eli Lilly and Company
GlaxoSmithKline (GSK)
AstraZeneca
Johnson & Johnson
Sanofi
Allergan (now a part of AbbVie)
Medtronic
Orexigen Therapeutics (acquired by Nalpropion Pharmaceuticals)
Arena Pharmaceuticals
Vivus
Eisai
Takeda Pharmaceuticals
Boehringer Ingelheim
Rhythm Pharmaceuticals
Zafgen (now part of Larimar Therapeutics)
Gelesis
Intarcia Therapeutics
Nalpropion Pharmaceuticals

Obesity Treatment Latest Industry Updates

In August, 2023, Novo Nordisk reported positive results from the SELECT trial, revealing that semaglutide 2.4 mg reduces major adverse cardiovascular events (MACE) by 20% in adults with overweight or obesity and established cardiovascular disease. The trial enrolled 17,604 adults, demonstrating statistically significant MACE reduction, with a well-tolerated profile. Semaglutide 2.4 mg, marketed as Wegovy, aims to revolutionize obesity treatment by offering effective weight management while lowering cardiovascular risks.

In September 2021, Allergan Plc (AbbVie) announced that the US Food and Drug Administration (FDA) approved its once-weekly GLP-1 receptor agonist, semaglutide, for the treatment of obesity to give patients with obesity and related conditions, such as type 2 diabetes, a new treatment option.
Obesity Treatment Market Segmentation Analysis
For the purpose of this report, Emergen Research has segmented the global obesity treatment market on the basis of treatment type, end-use, technology, cause, and region:

Treatment Type Outlook (Revenue, USD Billion; 2019-2032)

Pharmaceuticals
Prescription Drugs (e.g., Orlistat, Liraglutide)
Over-the-Counter (OTC) Drugs
Surgical Procedures:
Bariatric Surgery (e.g., Gastric Bypass, Sleeve Gastrectomy)
Liposuction
Dietary and Lifestyle Interventions:
Diet Plans and Programs
Physical Activity and Exercise Programs
Behavioral Therapy

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals and Clinics
Pharmacies:
Retail Pharmacies
Online Pharmacies
Fitness and Wellness Centers
Research and Academic Institutes

Technology Outlook (Revenue, USD Billion; 2019-2032)

Drug Delivery Technologies
Minimally Invasive Surgical Technologies
Telehealth and Digital Health Solutions
Cause Outlook (Revenue, USD Billion; 2019-2032)

Genetic Obesity
Diet-Induced Obesity
Lifestyle-Related Obesity

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2775

Regional Outlook (Revenue, USD Billion; 2019-2032)

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.